Skip to main content
Signal8

SELECT MEDICAL HOLDINGS CORP (SEM) Form 8-K — Jul 1, 2026

$SEMForm 8-KItems 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01Filed Jul 1, 2026, 9:27 AM ET0001104659-26-079643Original filing

Select Medical Holdings Corporation announced the consummation of its merger with Stallion MergerSub Corporation, effective as of July 1, 2026. As a result of the transaction, Select Medical has become an indirect wholly-owned subsidiary of Stallion Intermediate Corporation and is no longer a publicly traded entity. Public shareholders received $16.50 in cash for each share of common stock held, totaling an aggregate purchase price of approximately $1.7 billion. The transaction was financed through equity contributions from investors managed by affiliates of Welsh, Carson, Anderson & Stowe, as well as a new $1.0 billion Tranche B-3 term loan under the company’s credit agreement.

Key figures

Debt Amount
1000000000
Deal Value Usd
1700000000
Offering Price
16.5
Tranche B3 Term Loan Amount
1000000000
Merger Consideration Per Share
16.5

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.